Dilated Cardiomyopathy in Children: Early Detection and Treatment

Amrita Mallavarapu1, Amar Taksande2,3

  • 1Department of Paediatrics, Jawaharlal Nehru Medical College, Datta Meghe Institute of Medical Sciences, Wardha, IND.

Cureus
|December 7, 2022
PubMed

Insights

Dilated cardiomyopathy (DCM) involves heart enlargement and poor contractility, often leading to heart failure. Early detection and treatment, including heart transplantation, are crucial for managing this condition.

Area of Science:

  • Cardiology
  • Genetics
  • Internal Medicine

Background:

  • Cardiomyopathy presents as primary or secondary, with dilated cardiomyopathy (DCM) characterized by cardiac dilatation and impaired contractility.
  • Pediatric DCM involves dilated, contracting left ventricular defects and is associated with heart failure, stemming from various genetic and acquired causes.

Purpose of the Study:

  • To review diagnostic methods for dilated cardiomyopathy (DCM).
  • To highlight available treatment modalities for DCM.

Main Methods:

  • Literature review of cardiomyopathy classifications and phenotypes.
  • Analysis of diagnostic indicators for DCM, including imaging and clinical signs.
  • Overview of current and potential treatment strategies for DCM.

Main Results:

  • DCM manifests as left ventricular thinning, dilatation, systolic/diastolic dysfunction, and cardiomegaly, leading to symptoms like fatigue and dyspnea.
  • Rare forms like left ventricular non-compaction cardiomyopathy (LVNC) are linked to specific genetic mutations (DSG2, TBX20).
  • Complications include arrhythmias and thromboembolism, with heart transplantation as a definitive treatment for advanced DCM.

Conclusions:

  • Dilated cardiomyopathy encompasses diverse causes and presentations, significantly impacting cardiac function and overall health.
  • Accurate diagnosis through various methods is essential for effective management.
  • Heart transplantation remains a vital option for end-stage DCM, underscoring the importance of ongoing research and treatment advancements.

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
19
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
25
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
31
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
18
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
36
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
36